| 1 11m & kin, 1 _ WHMD Isbister, N Al Sanea | | |
| 15. Long and Short Outcomes After Laparoscopic Versus Open Curative Resection for Colon Cancer R Hakami, R Al Harbi, A Al Saffar, N Arab, I Al Mutiri, N Al Turki, SA Falah, ... European Journal of Surgical Oncology 44 (11), 1839, 2018 | | 2018 |
| 376 POSTER Genomic instability pathways in sporadic colorectal carcinomas of Saudi Arabia, molecular and tissue microarray analysis K Al-Kuraya, N Al Sanea, S Uddin, F Al Dayel, S Al Homoud, A Jabbar, ... European Journal of Surgical Oncology, S112, 2006 | | 2006 |
| A GENETIC LOOK AT MIDDLE EASTERN COLORECTAL CANCER KS Al-Kuraya, S Uddin, M Ahmed, A Hussain, F Al-Dayel, N Al-Sanea ANTICANCER RESEARCH 28 (5 C), 3191-3192, 2008 | | 2008 |
| A modern regimen of pre‐operative concurrent chemo‐radiation therapy in locally advanced rectal cancer S Bazarbashi, M el‐Bassiouni, M Abdelsalam, H Soudy, N Sanea, ... Journal of Surgical Oncology 98 (3), 167-174, 2008 | 18 | 2008 |
| A PILOT TRIAL OF PREOPERATIVE CHEMORADIOTHERAPY USING CAPECITABINE, EXTERNAL BEAM RADIATION AND CETUXIMAB FOLLOWED BY DEFINITIVE SURGERY IN PATIENTS WITH LOCALIZED (NON … H Soudy, A Aljubran, N Al Sanea, A Abduljabaar, S Al Homoud, L Ashari, ... ANNALS OF ONCOLOGY 21, 222-222, 2010 | 1 | 2010 |
| A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma AK Siraj, R Bu, S Prabhakaran, P Bavi, S Beg, M Al Hazmi, M Al-Rasheed, ... Molecular Cancer 13, 1-9, 2014 | 50 | 2014 |
| A20 gene promoter methylation confers resistance to colorectal carcinoma cell lines AK Siraj, M Al-Rasheed, P Bavi, A Hussain, N Al-Sanea, F Al-Dayel, ... Cancer Research 72 (8_Supplement), 4033-4033, 2012 | | 2012 |
| Aberrant promoter methylation of TMS1 gene in patients with colorectal carcinoma in Saudi Arabia S Uddin, AK Siraj, M Al-Rasheed, A Husain, P Bavi, N Al-Sanea, ... Cancer Research 71 (8_Supplement), 4813-4813, 2011 | | 2011 |
| Abstract# 1749: c-Met inhibitor potentiates TRAIL-induced apoptosis in human Colo-rectal cancer cells S Uddin, A Hussain, S Ahmed, M Ahmed, N Al-Sanea, A AbdulJabbar, ... Cancer Research 69 (9_Supplement), 1749-1749, 2009 | | 2009 |
| Abstract# 2438: Genome wide expression analysis of Middle Eastern CRC reveals FOX-M1 as a novel target for cancer therapy. A Siraj, P Bavi, M Sultana, J Abubaker, A Moorji, N Al-Sanea, F Al-Dayel, ... Cancer Research 69 (9_Supplement), 2438-2438, 2009 | | 2009 |
| Abstract# 2851: Prevalence of COX2 expression in Middle Eastern CRC and the effect of COX2 inhibitors on cell growth in the mouse model of CRC M Ahmed, P Bavi, A Hussain, N Al-Sanea, A Abduljabbar, L Ashari, ... Cancer Research 69 (9_Supplement), 2851-2851, 2009 | | 2009 |
| Abstract# 4851: KRAS alteration in the Middle Eastern CRC and its clinicopathological significance J Abubaker, P Bavi, W Al-Haqawi, A Moorji, N Al-Sanea, A Abduljabbar, ... Cancer Research 69 (9_Supplement), 4851-4851, 2009 | | 2009 |
| ACCURACY OF ENDOANAL ULTRASOUND IN LOCAL STAGING OF RECTAL CANCER POST CHEMORADIATION K Al Mulhim, A Abduljabbar, N Al Sanea, L Ashari, S Al Homoud ANNALS OF ONCOLOGY 20, 58-58, 2009 | | 2009 |
| ACCURACY OF RADIOLOGICAL IMAGING IN THE STAGING OF RECTAL CANCER AFTER NEOADJUVANT CHEMORADIATION. O Alamoudi, A Abduljabbar, L Ashari, S Alhomoud, H Alhomoud, ... DISEASES OF THE COLON & RECTUM 59 (5), E231-E232, 2016 | | 2016 |
| ALK gene amplification is associated with poor prognosis in colorectal carcinoma P Bavi, Z Jehan, R Bu, S Prabhakaran, N Al-Sanea, F Al-Dayel, ... British journal of cancer 109 (10), 2735-2743, 2013 | 42 | 2013 |
| APC truncating mutations in Middle Eastern population: Tankyrase inhibitor is an effective strategy to sensitize APC mutant CRC to 5-FU chemotherapy SK Parvathareddy, AK Siraj, R Bu, P Poyil, T Masoodi, DS Padmaja, ... Cancer Research 79 (13_Supplement), 3447-3447, 2019 | | 2019 |
| APC truncating mutations in Middle Eastern Population: Tankyrase inhibitor is an effective strategy to sensitize APC mutant CRC To 5-FU chemotherapy AK Siraj, SK Parvathareddy, P Pratheeshkumar, SP Divya, SO Ahmed, ... Biomedicine & Pharmacotherapy 121, 109572, 2020 | 18 | 2020 |
| Appendix 4–Excluded studies and primary reason for exclusion Ovid Search–excluded studies based on title/abstract RA Agha, EK Alexander, N Alsanea, E Altobelli | | |
| Bortezomib (Velcade) induces p27kip1 associated cell cycle arrest and apoptosis through down-regulation of SKP2 ubiquitin ligase pathway in colorectal carcinoma S Uddin, M Ahmed, P Bavi, N Al-Sanea, A AbdulJabbar, L Ashari, ... Cancer Research 68 (9_Supplement), 3265-3265, 2008 | | 2008 |
